Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee

LG Chem

Status: Completed

Conditions: Osteoarthritis in the Knee

Treatments: Drug: Synovian®

Study type: Observational

Funder types: Industry

Identifiers

NCT04369261

LG-HAOS006

Details and patient eligibility

About

This is an observational study to evaluate the injection site reactions of Synovian® Inj. in patients with osteoarthritis in the knee

Enrollment: 1,949 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult male or female patient of over 19 years of age
• A patient diagnosed with knee osteoarthritis
• A patient who has been informed of the purpose, method of the study and signed the written informed consent form.

Exclusion criteria

• A patient who shows hypersensitive reaction to the Synovian® Inj. or to the ingredients of Synovian® Inj.
• A patient with infection at the joint
• A patient with skin infection or skin disease at the injection area
• A patient diagnosed with osteoarthritis with the Kellgren & Lawrence Grade IV in X-ray within 12 months before enrollment of this study.